Skip to main content

Table 1 Baseline demographic and clinical characteristics of study patient

From: Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors

Variables Patients received antioxidants Patients received placebo p value
  n = 36 n = 34  
Age (y) 62.17 ± 6.21 62.97 ± 5.09 0.559
Male/Female 21/13 15/21 0.678
BMI 30.10 ± 4.04 29.83 ± 5.06 0.968
Current smokers, n (%) 8 (23.53%) 10 (27.8%) 0.684
Hypertension, n (%) 25 (75.53%) 26 (72.2%) 0.902
Diabetes mellitus, n (%) 13 (38.23%) 9 (25%) 0.233
Dyslipidemia, n (%) 26 (76.47%) 28 (77.8%) 0.896
Obesity, n (%) 17 (50%) 14 (38.9%) 0.349
Family history of IHD, n (%) 26 (76.5%) 27 (75%) 0.886
Concomitant medication:    
   Statins (%) 25 (73.53%) 27 (75%) 0.888
   ACEIs/ARBs (%) 19(55.88%) 12 (33.33%) 0.150
   Diuretics (%) 6 (17.64%) 2 (5.56%) 0.112
   B-blockers (%) 19 (55.89%) 16 (44.4%) 0.338
   CCB-blockers (%) 10 (29.41%) 11 (30.56%) 0.917
   Aspirin (%) 13 (38.23%) 16 (44.45%) 0.598
Baseline systolic BP (mm/Hg) 125.2 ± 25.4 138.0 ± 20.8 0.203
Baseline diastolic BP (mm/Hg) 78.4 ± 11.7 75.9 ± 7.8 0.291
Baseline fasting glucose (mg/dl) 127.1 ± 52.8 118.9 ± 42.2 0.476
Baseline HbA1C (%) 7.1 ± 1.7 6.8 ± 1.4 0.391
Baseline total cholesterol (mg/dl) 201.5 ± 53.1 198.8 ± 50.8 0.833
Baseline LDL Cholesterol (mg/dl) 117.5 ± 43.7 118.3 ± 47.1 0.945
Baseline HDL% 22.1 ± 4.6 26.0 ± 5.4 0.004
Baseline triglycerides (mg/dl) 189.5 ± 95.0 122.8 ± 56.5 0.001
Baseline hs-CRP (mg/dl) 1.84 ± 2.9 1.35 ± 1.6 0.616
Baseline endothelin(fmol/ml) 0.7 ± 2.6 1.4 ± 4.8 0.293
Baseline homocysteine (μmol/l) 9.2 ± 2.8 8.8 ± 3.1 0.486
Baseline renin (ng/ml/hr) 1.8 ± 3.4 1.5 ± 1.8 0.695
Baseline aldosteron (pg/ml) 7.4 ± 5.6 6.7 ± 4.5 0.590
Baseline urine cathacholamines (mg/24 h) 24.74 ± 22.4 19.5 ± 12.1 0.278